Neurodegenerative diseases require specific treatments in the field of physiotherapy that allow patients to regain mobility"

The wide variety of neurodegenerative diseases, complex diagnoses, different rates of progression and different prognoses, their multiple clinical manifestations, and rapid scientific and technical progress are all factors that necessitate specialized professionals in neurorehabilitation in order to ensure coordinated intervention in patients. Physiotherapists are a fundamental component in any multidisciplinary team, because these diseases cause alterations in various body activities, such as movement, balance, breathing, speech or heart functions.

That is why it is essential for physiotherapists to specialize in the treatment of these diseases in order to help those affected to improve symptoms, relieve pain, improve functional capacity, slow down the disabling process of the disease and stimulate independence and physical functions, since physiotherapy has proven to be effective in alleviating the consequences of neurodegenerative diseases.

To achieve this objective of providing these professionals with up-to-date education, TECH has designed this comprehensive Master's Degree, which has a teaching staff composed of specialists in the areas of intervention of each pathology, from health centers and prestigious universities, sensitized to quality continuing education based on scientific evidence to provide a holistic approach to the patient with neurodegenerative disease, and committed to quality teaching through new educational technologies.

In short, Master's Degree has set out to create contents of the highest teaching and educational quality that will turn students into successful professionals, following the highest quality standards in teaching at an international level. For this reason, TECH presents this program with a rich content that will help you reach the elite of neurological physiotherapy. 

Immerse yourself in this high-level Master's Degree and improve your skills in therapies for people with degenerative diseases"

This Master's Degree in Neurological Physiotherapy in Degenerative Diseases contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of numerous practical case studies presented by specialists in Neurological Physiotherapy
• The graphic, schematic and practical contents of the course are designed to provide all the essential information required for professional practice
• Exercises where the self-assessment process can be carried out to improve learning
• Algorithm-based interactive learning system for decision-making
• Special emphasis on innovative methodologies in Neurological Physiotherapy
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This Master's Degree is the best investment you can make when selecting a refresher program for two reasons: in addition to updating your knowledge in Neurological Physiotherapy, you will obtain a qualification from the world’s largest online university: TECH” 

It includes, in its teaching staff, professionals belonging to the field of physiotherapy, who contribute their vast work experience to this program, in addition to recognized specialists from leading societies and prestigious universities. 

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training programmed to train in real situations.
 
The design of this program focuses on Problem-Based Learning, whereby the physiotherapist must try to solve the different professional practice situations that arise throughout the program. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced experts in Neurological Physiotherapy in Degenerative Diseases .    

This Master's Degree offers practice in simulated environments, which provides an immersive learning experience designed to train for real-life situations"

A 100% online program will allow you to balance your studies with your professional work while increasing your knowledge in this field"

The structure of the contents has been designed by a team of professionals knowledgeable about the implications of training in daily practice, aware of the relevance of the current importance of quality education in the field of neurological physiotherapy, and committed to quality teaching through new educational technologies. 

We have the most complete and up-to-date scientific program on the market. We want to put the best education within your Master's Degree"

Module 1. Introduction to Neurodegenerative Diseases

1.1. Introduction

1.1.1. Definition
1.1.2. Classification
1.1.3. Epidemiology

1.2. Clinical/Symptoms

1.2.1. Symptoms
1.2.2. Signs
1.2.3. Diagnostic Imaging (Structural and Functional)

1.3. Quality of Life Rating Scales

1.3.1. Psychosocial Impact of Neurodegenerative Diseases and Quality of Life
1.3.2. Scales

1.4. Neurological Examination

1.4.1. Tone, Sensitivity, Osteotendinous Reflexes and Pathological Reflexes
1.4.2. Examination: Trunk, Upper Limb (Supporting, Reaching and Handling Function), Lower Limb (Static and Dynamic Standing)
1.4.3. Coordination, Balance and Gait
1.4.4. Cognitive Disorders
1.4.5. Cranial Nerves

1.5. Multidisciplinary team

1.5.1. Models of Teamwork in Neurorehabilitation
1.5.2. Neurorehabilitation Team Components

1.6. Physiotherapy Approach

1.6.1. Movement Facilitation Techniques
1.6.2. Therapeutic Exercise
1.6.3. Applied Neurodynamics

1.7. Other Methods

1.7.1. Hydrotherapy
1.7.2. Animal-Assisted Therapy
1.7.3. Robotics and Virtual Reality

1.8. Patient Complications

1.8.1. Pain
1.8.2. Cardio-Respiratory System Complications
1.8.3. Musculoskeletal Complications
1.8.4. Lymphatic Edema and Pressure Ulcers
1.8.5. Others

1.9. Patient, Caregiver and Family Information and Counseling
1.10. Digital Physiotherapy and Reporting

1.10.1. Telephysiotherapy
1.10.2. Scheduled Consultation via ICT
1.10.3. Writing a Physiotherapy Report
1.10.4. Interpretation of Medical Information

Module 2. Parkinson's Disease and Other Related Neurodegenerative Diseases (Progressive Supranuclear Palsy, Corticobasal Degeneration, Multiple Systemic Atrophy)

2.1. Introduction

2.1.1. Anatomy
2.1.2. Physiology
2.1.3. Classification
2.1.4. Epidemiology

2.2. Etiology

2.2.1. Transmission Mode
2.2.2. Frequency
2.2.3. Age of Onset

2.3. Progression/Prognostic Factors
2.4. Diagnosis

2.4.1. Clinical Manifestations
2.4.2. Diagnostic Imaging

2.5. Assessment

2.5.1. Neurological Examination
2.5.2. Neurological Assessment Scales

2.6. Treatment

2.6.1. Medical/Surgical Treatments
2.6.2. Occupational Therapy, Speech Therapy and Neuropsychology

2.7. Physiotherapy Treatment
2.8. Orthopedics

2.8.1. Support Products
2.8.2. Orthoses

2.9. Readaptation

2.9.1. Social Aspects/Support
2.9.2. Comprehensive Care for Patients, Families and Caregivers

2.10. Early Prevention and Detection

Module 3. Multiple Sclerosis

3.1. Introduction

3.1.1. Anatomy
3.1.2. Physiology
3.1.3. Classification
3.1.4. Epidemiology

3.2. Etiology

3.2.1. Transmission Mode
3.2.2. Frequency
3.2.3. Starting Age

3.3. Progression/Prognostic Factors
3.4. Diagnosis

3.4.1. Clinical Manifestations
3.4.2. Diagnostic Imaging

3.5. Assessment

3.5.1. Neurological Examination
3.5.2. Neurological Assessment Scales

3.6. Treatment

3.6.1. Medical/Surgical Treatments
3.6.2. Occupational Therapy, Speech Therapy and Neuropsychology

3.7. Physiotherapy Treatment
3.8. Orthopedics

3.8.1. Support Products
3.8.2. Orthoses

3.9. Readaptation

3.9.1. Social Aspects/Support
3.9.2. Comprehensive Care for Patients, Families and Caregivers

3.10. Early Prevention and Detection

Module 4. Amyotrophic Lateral Sclerosis

4.1. Introduction

4.1.1. Anatomy
4.1.2. Physiology
4.1.3. Classification
4.1.4. Epidemiology

4.2. Etiology

4.2.1. Transmission Mode
4.2.2. Frequency
4.2.3. Starting Age

4.3. Progression/Prognostic Factors
4.4. Diagnosis

4.4.1. Clinical Manifestations
4.4.2. Diagnostic Imaging

4.5. Assessment

4.5.1. Neurological Examination
4.5.2. Neurological Assessment Scales

4.6. Treatment

4.6.1. Medical-surgical Treatments
4.6.2. Occupational Therapy, Speech Therapy and Neuropsychology

4.7. Physiotherapy Treatment
4.8. Orthopedics

4.8.1. Support Products
4.8.2. Orthoses

4.9. Readaptation

4.9.1. Social Aspects/Support
4.9.2. Comprehensive Care for Patients, Families and Caregivers

4.10. Early Prevention and Detection

Module 5. Huntington's Disease

5.1. Introduction

5.1.1. Anatomy
5.1.2. Physiology
5.1.3. Classification
5.1.4. Epidemiology

5.2. Etiology

5.2.1. Transmission Mode
5.2.2. Frequency
5.2.3. Starting Age

5.3. Progression/Prognostic Factors
5.4. Diagnosis

5.4.1. Clinical Manifestations
5.4.2. Diagnostic Imaging

5.5. Assessment

5.5.1. Neurological Examination
5.5.2. Neurological Assessment Scales

5.6. Treatment

5.6.1. Medical/Surgical Treatments
5.6.2. Occupational Therapy, Speech Therapy and Neuropsychology

5.7. Physiotherapy Treatment
5.8. Orthopedics

5.8.1. Support Products
5.8.2. Orthoses

5.9. Readaptation

5.9.1. Social Aspects/Support
5.9.2. Comprehensive Care for Patients, Families and Caregivers

5.10. Early Prevention and Detection

Module 6. Neuromuscular Diseases and Polyneuropathies

6.1. Introduction

6.1.1. Anatomy
6.1.2. Physiology
6.1.3. Classification
6.1.4. Epidemiology

6.2. Etiology

6.2.1. Transmission Mode
6.2.2. Frequency
6.2.3. Starting Age

6.3. Progression/Prognostic Factors
6.4. Diagnosis

6.4.1. Clinical Manifestations
6.4.2. Diagnostic Imaging

6.5. Assessment

6.5.1. Neurological Examination
6.5.2. Neurological Assessment Scales

6.6. Treatment

6.6.1. Medical/Surgical Treatments
6.6.2. Occupational Therapy, Speech Therapy and Neuropsychology

6.7. Physiotherapy Treatment
6.8. Orthopedics

6.8.1. Support Products
6.8.2. Orthoses

6.9. Readaptation

6.9.1. Social Aspects/Support
6.9.2. Comprehensive Care for Patients, Families and Caregivers

6.10. Early Prevention and Detection
  

Module 7. Alzheimer's Disease and Other Neurodegenerative Dementias: Frontotemporal Dementia, Lewy Body Dementia, Vascular Dementia

7.1. Introduction

7.1.1. Anatomy
7.1.2. Physiology
7.1.3. Classification
7.1.4. Epidemiology

7.2. Etiology

7.2.1. Transmission Mode
7.2.2. Frequency
7.2.3. Starting Age

7.3. Progression/Prognostic Factors
7.4. Diagnosis

7.4.1. Clinical Manifestations
7.4.2. Diagnostic Imaging

7.5. Assessment

7.5.1. Neurological Examination
7.5.2. Neurological Assessment Scales

7.6. Treatment

7.6.1. Medical/Surgical Treatments
7.6.2. Occupational Therapy, Speech Therapy and Neuropsychology

7.7. Physiotherapy Treatment
7.8. Orthopedics

7.8.1. Support Products
7.8.2. Orthoses

7.9. Readaptation

7.9.1. Social Aspects/Support
7.9.2. Comprehensive Care for Patients, Families and Caregivers

7.10. Early Prevention and Detection

Module 8. Cerebellar Degenerative Diseases: Hereditary Ataxias: Friedreich's Ataxia and Machado-Joseph Ataxia

8.1. Introduction

8.1.1. Anatomy
8.1.2. Physiology
8.1.3. Classification
8.1.4. Epidemiology

8.2. Etiology

8.2.1. Transmission Mode
8.2.2. Frequency
8.2.3. Starting Age

8.3. Progression/Prognostic Factors
8.4. Diagnosis

8.4.1. Clinical Manifestations
8.4.2. Diagnostic Imaging

8.5. Assessment

8.5.1. Neurological Examination
8.5.2. Neurological Assessment Scales

8.6. Treatment

8.6.1. Medical/Surgical Treatments
8.6.2. Occupational Therapy, Speech Therapy and Neuropsychology

8.7. Physiotherapy Treatment
8.8. Orthopedics

8.8.1. Support Products
8.8.2. Orthoses

8.9. Readaptation

8.9.1. Social Aspects/Support
8.9.2. Comprehensive Care for Patients, Families and Caregivers

8.10. Early Prevention and Detection

Module 9. Neurodegenerative Diseases in Childhood

9.1. Introduction

9.1.1. Neurodevelopment/Embryology
9.1.2. Classification

9.2. Epidemiology
9.3. Etiology

9.3.1. Frequency
9.3.2. Age of Onset

9.4. Evolution
9.5. Prognostic Factors
9.6. Evaluation/Diagnosis

9.6.1. Clinical Manifestations
9.6.2. Neurological Examination
9.6.3. Neurological Assessment Scales

9.7. Treatment

9.7.1. Medical/Surgical Treatments
9.7.2. Physiotherapy
9.7.3. Occupational Therapy, Speech Therapy and Neuropsychology

9.8. Orthopedics

9.8.1. Support Products
9.8.2. Orthoses

9.9. Readaptation

9.9.1. Social Aspects/Support
9.9.2. Comprehensive Care for Patients, Families and Caregivers

9.10. Early Prevention and Detection

Module 10. Neoplasms or Nervous System Tumors 

10.1. Introduction

10.1.1. Anatomy
10.1.2. Physiology
10.1.3. Classification
10.1.4. Epidemiology

10.2. Etiology

10.2.1. Transmission Mode
10.2.2. Frequency
10.2.3. Starting Age

10.3. Progression/Prognostic Factors
10.4. Diagnosis

10.4.1. Clinical Manifestations
10.4.2. Diagnostic Imaging

10.5. Assessment

10.5.1. Neurological Examination
10.5.2. Neurological Assessment Scales

10.6. Treatment

 10.6.1. Medical-surgical Treatments
 10.6.2. Occupational Therapy, Speech Therapy and Neuropsychology

10.7. Physiotherapy Treatment
10.8. Orthopedics

 10.8.1. Support Products
 10.8.2. Orthoses

10.9. Readaptation

 10.9.1. Social Aspects/Support
 10.9.2. Comprehensive Care for Patients, Families and Caregivers

10.10. Early Prevention and Detection

A unique specializacion program that will allow you to acquire advanced training in this field"